Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
Manchester research means women diagnosed with womb cancer should now be routinely screened for the genetic condition Lynch syndrome (LS), following a new guideline issued by the National Institute for Health and Care Excellence (NICE).
Continue reading full article: Manchester research leads to NICE recommendation for Lynch syndrome screening for womb cancer patients
Professor Paul Dark, Non-fungal Infections Programme Lead and researchers from a leading NIHR study are investigating how to improve the use of antibiotics for patients with COVID-19 at risk of sepsis.
Continue reading full article: Manchester BRC researcher examines antibiotic treatment for sepsis in COVID-19
A lupus patient at the Manchester Royal Infirmary was the first UK recruit to the newly launched NIHR IMID BioResource – a national database of inflammatory disease patients willing to participate in research.
Continue reading full article: Manchester lupus patient first recruit to NIHR IMID BioResource
A new national project investigating changes in radiotherapy services during COVID-19 has been launched by a team of Manchester cancer clinicians.
Continue reading full article: Manchester launches national project to understand changes in radiotherapy treatment for lung cancer patients during COVID-19
Manchester cancer researcher Professor Gareth Evans was recently recognised for his work in advancing women’s health, after receiving a prestigious honorary fellowship by the Royal College of Obstetricians and Gynaecologists (RCOG).
Continue reading full article: Manchester cancer professor receives honour from Royal College of Obstetricians and Gynaecologists
Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry of psoriasis and COVID-19 patients, in research supported by NIHR Manchester Biomedical Research Centre (BRC).
Continue reading full article: Most psoriasis patients taking drugs that affect the immune system survive COVID-19
This MAHSC Seminar Series event will showcase the great discovery and clinical science being undertaken in Manchester, and the impact of cancer prevention and early detection research on the population.
Continue reading full article: Online Event – MAHSC Seminar Series: Cancer Prevention and Early Detection
Around 550 million people have chronic obstructive pulmonary disease (COPD), according to two University of Manchester medical students working with senior researchers supported by Manchester BRC. The figure is more than double the previous estimate by WHO.
Continue reading full article: Prevalence of lung condition more than double WHO figures, find students